ATE302197T1 - Amidderivate - Google Patents
AmidderivateInfo
- Publication number
- ATE302197T1 ATE302197T1 AT01981033T AT01981033T ATE302197T1 AT E302197 T1 ATE302197 T1 AT E302197T1 AT 01981033 T AT01981033 T AT 01981033T AT 01981033 T AT01981033 T AT 01981033T AT E302197 T1 ATE302197 T1 AT E302197T1
- Authority
- AT
- Austria
- Prior art keywords
- accompanied
- amide derivative
- infection
- herpes
- hsv
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/70—Sulfur atoms
- C07D277/74—Sulfur atoms substituted by carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000344354 | 2000-11-10 | ||
| PCT/JP2001/009790 WO2002038554A1 (fr) | 2000-11-10 | 2001-11-08 | Derives amides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE302197T1 true ATE302197T1 (de) | 2005-09-15 |
Family
ID=18818562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01981033T ATE302197T1 (de) | 2000-11-10 | 2001-11-08 | Amidderivate |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6949543B2 (de) |
| EP (1) | EP1340750B8 (de) |
| JP (1) | JP3913172B2 (de) |
| KR (1) | KR20030045180A (de) |
| CN (1) | CN1473157A (de) |
| AT (1) | ATE302197T1 (de) |
| AU (1) | AU2002212734A1 (de) |
| CA (1) | CA2428184C (de) |
| DE (1) | DE60112790T2 (de) |
| ES (1) | ES2247177T3 (de) |
| WO (1) | WO2002038554A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003095435A1 (fr) * | 2002-05-09 | 2003-11-20 | Yamanouchi Pharmaceutical Co., Ltd. | Derives d'amides |
| TW200505894A (en) | 2003-08-08 | 2005-02-16 | Yamanouchi Pharma Co Ltd | Tetrahydro-2H-thiopyran-4-carboxamide derivative |
| JP5010917B2 (ja) * | 2003-08-29 | 2012-08-29 | エグゼリクシス， インコーポレイテッド | ｃ−Ｋｉｔ調節因子および使用方法 |
| CA2553442A1 (en) * | 2004-02-11 | 2005-08-25 | Irm Llc | Compounds and compositions as lxr modulators |
| CA2562714A1 (en) * | 2004-05-13 | 2005-11-24 | Boehringer Ingelheim International Gmbh | Substituted thiophene-2-carboxylic acid amides, the production thereof and the use thereof as drugs |
| JPWO2006082821A1 (ja) * | 2005-02-02 | 2008-06-26 | アステラス製薬株式会社 | ヘルペスウイルスが関与する疾患の予防若しくは治療剤 |
| CA2596850A1 (en) * | 2005-02-02 | 2006-08-10 | Astellas Pharma Inc. | Medicament for genital herpes |
| WO2006082822A1 (ja) * | 2005-02-02 | 2006-08-10 | Astellas Pharma Inc. | アシクロビル耐性ヘルペスウイルスによる疾患の予防・治療剤 |
| JP4832093B2 (ja) * | 2005-02-02 | 2011-12-07 | アステラス製薬株式会社 | テトラヒドロ−２ｈ−チオピラン−４−カルボキサミド誘導体の製造方法 |
| JP5011739B2 (ja) * | 2005-02-03 | 2012-08-29 | アステラス製薬株式会社 | テトラヒドロ−２ｈ−チオピラン−４−カルボキサミド誘導体を含有する医薬組成物 |
| CA2661863A1 (en) * | 2006-08-30 | 2008-03-06 | F. Hoffmann-La Roche Ag | Inhibitors for glyt-1 |
| US9403789B2 (en) | 2008-02-21 | 2016-08-02 | Sequoia Pharmaceuticals, Inc. | Benzofuran-containing amino acid inhibitors of cytochrome P450 |
| EP2351565A1 (de) | 2008-10-20 | 2011-08-03 | Astellas Pharma Inc. | Medizin zur verhinderung oder behandlung von schmerzen aufgrund von gürtelrose |
| US9212134B2 (en) | 2010-09-13 | 2015-12-15 | Microbiotix, Inc. | Inhibitors of viral entry into mammalian cells |
| JP5641054B2 (ja) * | 2010-12-03 | 2014-12-17 | 富士通株式会社 | 新規化合物、並びに、キネシンスピンドルタンパク質阻害剤及びその応用 |
| CN103275034B (zh) * | 2013-04-16 | 2015-07-08 | 南京工业大学 | 一类小分子cathepsin D抑制剂的制备方法 |
| TW202038947A (zh) | 2018-11-28 | 2020-11-01 | 德商創新分子有限責任公司 | 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997024343A1 (en) * | 1995-12-29 | 1997-07-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Phenyl thiazole derivatives with anti herpes virus properties |
| AU3289299A (en) * | 1998-02-19 | 1999-09-06 | Tularik Inc. | Antiviral agents |
| WO2000029399A1 (en) * | 1998-11-12 | 2000-05-25 | Boehringer Ingelheim (Canada) Ltd. | Antiherpes compounds |
-
2001
- 2001-11-08 CN CNA018184316A patent/CN1473157A/zh active Pending
- 2001-11-08 ES ES01981033T patent/ES2247177T3/es not_active Expired - Lifetime
- 2001-11-08 JP JP2002541089A patent/JP3913172B2/ja not_active Expired - Fee Related
- 2001-11-08 WO PCT/JP2001/009790 patent/WO2002038554A1/ja active IP Right Grant
- 2001-11-08 CA CA2428184A patent/CA2428184C/en not_active Expired - Fee Related
- 2001-11-08 EP EP01981033A patent/EP1340750B8/de not_active Expired - Lifetime
- 2001-11-08 US US10/416,371 patent/US6949543B2/en not_active Expired - Fee Related
- 2001-11-08 AU AU2002212734A patent/AU2002212734A1/en not_active Abandoned
- 2001-11-08 DE DE60112790T patent/DE60112790T2/de not_active Expired - Lifetime
- 2001-11-08 AT AT01981033T patent/ATE302197T1/de not_active IP Right Cessation
- 2001-11-08 KR KR10-2003-7006347A patent/KR20030045180A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030045180A (ko) | 2003-06-09 |
| US6949543B2 (en) | 2005-09-27 |
| EP1340750A1 (de) | 2003-09-03 |
| CA2428184C (en) | 2010-03-30 |
| EP1340750A4 (de) | 2004-01-21 |
| AU2002212734A1 (en) | 2002-05-21 |
| ES2247177T3 (es) | 2006-03-01 |
| CA2428184A1 (en) | 2002-05-16 |
| US20040034232A1 (en) | 2004-02-19 |
| WO2002038554A1 (fr) | 2002-05-16 |
| DE60112790T2 (de) | 2006-05-18 |
| EP1340750B8 (de) | 2005-10-19 |
| DE60112790D1 (de) | 2005-09-22 |
| JPWO2002038554A1 (ja) | 2004-03-18 |
| JP3913172B2 (ja) | 2007-05-09 |
| CN1473157A (zh) | 2004-02-04 |
| EP1340750B1 (de) | 2005-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60112790D1 (de) | Amidderivate | |
| CY1115461T1 (el) | Παραγωγα αμιδιων | |
| ES2160046A1 (es) | Derivados pentapeptidicos. | |
| ATE229945T1 (de) | Zur behandlung von cmv infektionen geeignete 1,3, 4-thiadiazole | |
| ATE245641T1 (de) | Antivirale pyrimidinderivate | |
| AP1753A (en) | Thiophene derivatives as antiviral agents for flavvivirus infection | |
| BRPI0411900A (pt) | compostos antivirais e métodos | |
| WO2011060408A3 (en) | 2'-fluoro-6'-methylene carbocyclic nucleosides and methods of treating viral infections | |
| ES2134764T3 (es) | Inhibidores de hiv proteasa. | |
| ATE512973T1 (de) | Nukleosid-arylphosphoramidate und ihre verwendung als antivirale mittel zur behandlung von hepatitis-c-virus | |
| ATE231149T1 (de) | (1,8)-naphthyridinderivate derivate mit antiviraler wirkung | |
| ATE254132T1 (de) | Antivirale pyrimidin nucleoside derivate | |
| ES2138983T3 (es) | Uso de derivados del acido 2-(n-(2-aminoetil)amino)-acetico para el tratamiento de enfermedades condicionadas por glicosilacion no enzimatica. | |
| DE69624813T2 (de) | Robustaflavon und dessen derivate als antivirales mittel | |
| NO20012834D0 (no) | Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus | |
| BR0215067A (pt) | Piridoquinoxalinas antivirais | |
| DE59704973D1 (de) | Nucleosid-derivate mit photolabilen schutzgruppen | |
| ES2111700T3 (es) | Derivados de cis-epoxidos, utilizables como inhibidores irreversibles de la proteasa de hiv, y procedimientos e intermediarios para su preparacion. | |
| NO20012838L (no) | Tiourea-inhibitorer for herpesvirus | |
| TR200101664T2 (tr) | Fenilendiamin grubu ieren herpesviruslarìn heteroksiklik karboksamid ieren tiore inhibitrleri | |
| DK2016081T3 (da) | Antivirale pyrimidinnukleosidderivater, antivirale pyrimidinnukleosidderivater | |
| ATE124050T1 (de) | Chirale 2-(phosphonomethoxy)propyl-guanine als antivirale agentien. | |
| EA200100711A1 (ru) | Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция | |
| DE69731483D1 (de) | Beta-l-dioxolanuridin-analoge zur behandlung und vorbeugung von durch ebv, vzv bzw. hv-8 verursachten viralen infektionen | |
| EP1844776A4 (de) | Wirkstoff zur prävention/behandlung von erkrankungen infolge von acyclovir-resistentem herpesvirus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |